{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:14:09Z","timestamp":1780341249279,"version":"3.54.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0206912","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T18:16:20Z","timestamp":1541182580000},"page":"e0206912","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015)"],"prefix":"10.1371","volume":"13","author":[{"given":"Andreia N.","family":"Hor\u00e1cio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Silva-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00edsia","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4084-6233","authenticated-orcid":true,"given":"M\u00e1rio","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Melo-Cristino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Portuguese Group for the Study of Streptococcal Infections","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e60273","DOI":"10.1371\/journal.pone.0060273","article-title":"Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques","volume":"8","author":"MA Said","year":"2013","journal-title":"PloS One"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"T Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.12.20750","article-title":"Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012","volume":"19","author":"SI Aguiar","year":"2014","journal-title":"Euro Surveill"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073704","article-title":"The majority of adult pneumococcal invasive infections in Portugal are still potentially vaccine preventable in spite of significant declines of serotypes 1 and 5","volume":"8","author":"AN Hor\u00e1cio","year":"2013","journal-title":"PLoS ONE"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3389\/fmicb.2016.01616","article-title":"Serotype 3 remains the leading cause of invasive pneumococcal disease in adults in Portugal (2012\u20132014) despite continued reductions in other 13-valent conjugate vaccine serotypes","volume":"7","author":"AN Hor\u00e1cio","year":"2016","journal-title":"Front Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"PA Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"MR Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.vaccine.2016.03.052","article-title":"Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay","volume":"34","author":"MW Pletz","year":"2016","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1183\/09031936.00183614","article-title":"Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia","volume":"45","author":"C Rodrigo","year":"2015","journal-title":"Eur Respir J"},{"key":"ref11","article-title":"Non-invasive <italic>Streptococcus pneumoniae<\/italic> serotypes recovered from hospitalized adult patients in the United States (2009\u20132012)","author":"RE Mendes","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10096-016-2834-2","article-title":"Changes in the pneumococcal disease-related hospitalisations in Spain after the replacement of 7-valent by 13-valent conjugate vaccine","volume":"36","author":"L Georgalis","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1016\/j.vaccine.2016.05.002","article-title":"Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly","volume":"34","author":"CH van Werkhoven","year":"2016","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e103092","DOI":"10.1371\/journal.pone.0103092","article-title":"Non-invasive pneumococcal pneumonia in Portugal\u2014serotype distribution and antimicrobial resistance","volume":"9","author":"AN Hor\u00e1cio","year":"2014","journal-title":"PLoS ONE"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e72743","DOI":"10.1371\/journal.pone.0072743","article-title":"Serotype distribution in non-bacteremic pneumococcal pneumonia: association with disease severity and implications for pneumococcal conjugate vaccines","volume":"8","author":"T Benfield","year":"2013","journal-title":"PloS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1469-0691.2008.02031.x","article-title":"Changes in <italic>Streptococcus pneumoniae<\/italic> serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine","volume":"14","author":"SI Aguiar","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"ref17","article-title":"Serotype 3 remains a leading cause of complicated pediatric pneumococcal pneumonia even among PCV13 vaccinated children","author":"C Silva-Costa","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"ref18","unstructured":"Direc\u00e7\u00e3o Geral de Sa\u00fade. Norma 11\/2015 -Vacina\u00e7\u00e3o contra infe\u00e7\u00f5es por Streptococcus pneumoniae de grupos com risco acrescido para doen\u00e7a invasiva pneumoc\u00f3cica (DIP). Adultos (\u226518 anos de idade). 2015."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.rppneu.2014.02.001","article-title":"Consensus document for the prevention of respiratory infections in adults","volume":"20","author":"F Fr\u00f5es","year":"2014","journal-title":"Rev Port Pneumol"},{"key":"ref20","first-page":"70","article-title":"A doen\u00e7a pneumoc\u00f3cica e recomenda\u00e7\u00f5es GRESP para a vacina\u00e7\u00e3o antipneumoc\u00f3cica na popula\u00e7\u00e3o adulta (\u226518 anos)","volume":"32","author":"RP Costa","year":"2016","journal-title":"Rev Port Med Geral E Fam"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.32385\/rpmgf.v25i5.10666","article-title":"Avalia\u00e7\u00e3o da qualidade da prescri\u00e7\u00e3o da vacina anti-pneumoc\u00f3cica aos idosos","volume":"25","author":"M Sousa","year":"2009","journal-title":"Rev Port Cl\u00ednica Geral"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1586\/erv.11.99","article-title":"Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe","volume":"10","author":"DS Fedson","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1128\/JCM.31.8.2097-2100.1993","article-title":"Typing of pneumococci by using 12 pooled antisera","volume":"31","author":"UB S\u00f8rensen","year":"1993","journal-title":"J Clin Microbiol"},{"key":"ref24","article-title":"Performance standards for antimicrobial susceptibility testing\u2014seventeenth informational supplement","year":"2007"},{"key":"ref25","article-title":"Performance standards for antimicrobial susceptibility testing\u2014twenty-fifth informational supplement","year":"2015"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1128\/JCM.02536-05","article-title":"Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant <italic>Streptococcus pyogenes<\/italic>","volume":"44","author":"JA Carri\u00e7o","year":"2006","journal-title":"J Clin Microbiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate\u2014a practical and powerful approach to multiple testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/ciu524","article-title":"Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality","volume":"59","author":"ZB Harboe","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1016\/j.vaccine.2013.10.032","article-title":"Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway","volume":"31","author":"A Steens","year":"2013","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study","volume":"18","author":"SN Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/JCM.01763-10","article-title":"Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype","volume":"49","author":"R S\u00e1-Le\u00e3o","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e0153602","DOI":"10.1371\/journal.pone.0153602","article-title":"Population structure of <italic>Streptococcus pneumoniae<\/italic> causing invasive disease in adults in Portugal before PCV13 availability for adults: 2008\u20132011","volume":"11","author":"AN Hor\u00e1cio","year":"2016","journal-title":"PloS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.vaccine.2011.11.022","article-title":"Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections","volume":"30","author":"AN Hor\u00e1cio","year":"2012","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/cit233","article-title":"Resurgence of serotype 19F carriage in preschool children in Portugal in the context of continuing moderate conjugate pneumococcal vaccine uptake","volume":"57","author":"F Rodrigues","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1016\/j.vaccine.2016.06.017","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on <italic>Streptococcus pneumoniae<\/italic> multiple serotype carriage","volume":"34","author":"C Valente","year":"2016","journal-title":"Vaccine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0206912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:50:33Z","timestamp":1720745433000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0206912"}},"subtitle":[],"editor":[{"given":"Daniela Flavia","family":"Hozbor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0206912","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,2]]}}}